ArticleFrontiers in oncology2025

Safety assessment of ripretinib: a real-world adverse event analysis from the food and drug administration adverse event reporting system.

Sentai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.